(Department of Urology,The Second Hospital , Tianjin Medical University,Tianjin Institute of Urology, Tianjin 300211,China)
?
Objective: To study antitumor effect and mechanism of action on recombinant IFN-α-2b-BCG in vitro. Methods: Effect of rBCG on bladder tumor cells was observed through transmission electro microscopy and microscope. Acridine orange staining was used to observe the tumor cellsmorphology by fluorescence microscope. Growth? inhibition rate on tumor cell was detected by MTT assay. Effect of rBCG cultures on secretion of Th1-type cytokines was detected by ELISA assay. LDH release assay was applied to determine the lethal effect of active lymphocyte which was stimulated by BCG on umor cells. Results:The rBCG group showed significant changes. MTT showed rBCG inhibited the proliferation of bladder cancer cell, and more active other groups. RBCG cultures affected the section of Th1 cytokines. And rBCG could enhanced the lethal effect of lymphocyte on tumor cells. Conclusion: The rBCG may have more immunomodulatory properties, anti-tumor effects and cytotoxicity in vitro.
?
[1]Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):E359
[2]韩苏军,张思维,陈万青,等. 中国膀胱癌发病现状及流行趋势分析[J].癌症进展,2013,11(1):89
[3]Kamat A M, Porten S. Myths and mysteries surrounding bacillus Calmette-Guérin therapy for bladder Cancer[J].Eur Urol, 2014, 65 (2):267
[4]Lamm D L. Bacille Calmette-Guérin immunotherapy for bladder Cancer[J].Journal of Urology ,1985,134(1):40
[5]Herr H W, Wartinger D D, Fair W R, et al. Bacillus Calmette-Guerin therapy for superficial bladder Cancer: a 10-year followup[J].J Urol,1992,147(4):1020
[6]Sylvester R J, van der Meijden A P, Lamm D L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder Cancer: a meta-analysis of the published results of randomized clinical trials[J].J Urol,2002,168(5):1964
[7]von Rundstedt F C, Lerner S P. Bacille-Calmette-Guerin non-responders: how to manage[J].Transl Androl Urol,2015,4(3):244
[8]Xiao Z, Hanel E, Mak A, et al. Antitumor efficacy of intravesical BCG, gemcitabine, interferon-α and interleukin-2 as mono- or Combination-Therapy for bladder Cancer in an orthotopic tumor model[J].Clin Med Insights Oncol,2011,5(5):315
[9]孙二琳,刘春雨,韩瑞发,等. 重组hIFN-α-2B-BCG的生物学特性的观察[J].中华微生物学和免疫学杂志,2010,30(1):46
[10]Herr H W, Morales A. History of bacillus Calmette-Guerin and bladder Cancer: an immunotherapy success story[J].J Urol,2008,179(1):53
[11]Thompson D B, Siref L E, Feloney M P, et al. Immunological basis in the pathogenesis and treatment of bladder Cancer[J].Expert Rev Clin Immunol,2015,11(2):265
[12]Rajala P, Kaasinen E, Rintala E, et al. Cytostatic effect of different strains of Bacillus Calmette-Guérin on human bladder Cancer cells in vitro alone and in combination with mitomycin C and interferon-alpha[J].Urol Res,1992,20(3):215
[13]Garcia C, Jina H, Bergersen P, et al. Bladder contracture - A rare and serious side effect of intravesical bacillus Calmette-Guérin therapy[J].Urology case reports,2016,4:22
[14]Moriwaki Y, Begum N A, Kobayashi M, et al. Mycobacterium bovis Bacillus calmette-Guerin and its cell wall complex induce a novel lysosolipopo-lysaccharide and p53-inducible gene,LITAF(PIG7),and estrogen-inducible gene,EET-1[J].J Biol Chem,2001,276(25):23065
[15]Ryll R, Watanabe K, Fujiwara N, et al. Mycobacterial cord factor,but not sulfolipid,causes depletion of NKT cells and upregulation of CD1d1 on murine macrophages[J].Microbes Infect,2001,3(8):611
[16]董亚利,白景文,沈伟,等. BCG对体外培养人癌细胞直接作用的扫描电镜观察[J].天津医科大学学报,1995,1(2):23
基金项目 国家自然科学基金资助项目(81402095);天津市科委抗癌重大科技专项基金资助项目(12zcdzsy16900);天津市卫计委科技基金资助项目(2014KZ104)
作者简介 王丽宁(1989-),女,研究实习员,学士,研究方向:泌尿外科基础医学;
通信作者:孙二琳,E-mail:irene_sunsun@163.com。
?